OBJECTIVES: This study sought to determine an aggregate, pathway-specific risk score for enhanced prediction of death and myocardial infarction (MI). BACKGROUND: Activation of inflammatory, coagulation, and cellular stress pathways contribute to atherosclerotic plaque rupture. We hypothesized that an aggregate risk score comprised of biomarkers involved in these different pathways-high-sensitivity C-reactive protein (CRP), fibrin degradation products (FDP), and heat shock protein 70 (HSP70) levels-would be a powerful predictor of death and MI. METHODS: Serum levels of CRP, FDP, and HSP70 were measured in 3,415 consecutive patients with suspected or confirmed coronary artery disease (CAD) undergoing cardiac catheterization. Survival analyses were performed with models adjusted for established risk factors. RESULTS: Median follow-up was 2.3 years. Hazard ratios (HRs) for all-cause death and MI based on cutpoints were as follows: CRP ≥3.0 mg/l, HR: 1.61; HSP70 >0.625 ng/ml, HR; 2.26; and FDP ≥1.0 μg/ml, HR: 1.62 (p < 0.0001 for all). An aggregate biomarker score between 0 and 3 was calculated based on these cutpoints. Compared with the group with a 0 score, HRs for all-cause death and MI were 1.83, 3.46, and 4.99 for those with scores of 1, 2, and 3, respectively (p for each: <0.001). Annual event rates were 16.3% for the 4.2% of patients with a score of 3 compared with 2.4% in 36.4% of patients with a score of 0. The C statistic and net reclassification improved (p < 0.0001) with the addition of the biomarker score. CONCLUSIONS: An aggregate score based on serum levels of CRP, FDP, and HSP70 is a predictor of future risk of death and MI in patients with suspected or known CAD.
OBJECTIVES: This study sought to determine an aggregate, pathway-specific risk score for enhanced prediction of death and myocardial infarction (MI). BACKGROUND: Activation of inflammatory, coagulation, and cellular stress pathways contribute to atherosclerotic plaque rupture. We hypothesized that an aggregate risk score comprised of biomarkers involved in these different pathways-high-sensitivity C-reactive protein (CRP), fibrin degradation products (FDP), and heat shock protein 70 (HSP70) levels-would be a powerful predictor of death and MI. METHODS: Serum levels of CRP, FDP, and HSP70 were measured in 3,415 consecutive patients with suspected or confirmed coronary artery disease (CAD) undergoing cardiac catheterization. Survival analyses were performed with models adjusted for established risk factors. RESULTS: Median follow-up was 2.3 years. Hazard ratios (HRs) for all-cause death and MI based on cutpoints were as follows: CRP ≥3.0 mg/l, HR: 1.61; HSP70 >0.625 ng/ml, HR; 2.26; and FDP ≥1.0 μg/ml, HR: 1.62 (p < 0.0001 for all). An aggregate biomarker score between 0 and 3 was calculated based on these cutpoints. Compared with the group with a 0 score, HRs for all-cause death and MI were 1.83, 3.46, and 4.99 for those with scores of 1, 2, and 3, respectively (p for each: <0.001). Annual event rates were 16.3% for the 4.2% of patients with a score of 3 compared with 2.4% in 36.4% of patients with a score of 0. The C statistic and net reclassification improved (p < 0.0001) with the addition of the biomarker score. CONCLUSIONS: An aggregate score based on serum levels of CRP, FDP, and HSP70 is a predictor of future risk of death and MI in patients with suspected or known CAD.
Authors: W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe Journal: Circulation Date: 1975-04 Impact factor: 29.690
Authors: Burton E Sobel; Regina M Hardison; Saul Genuth; Maria M Brooks; Robert D McBane; David J Schneider; Richard E Pratley; Kurt Huber; Robert Wolk; Ashok Krishnaswami; Robert L Frye Journal: Circulation Date: 2011-07-18 Impact factor: 29.690
Authors: John Hill; Claire Heslop; S F Paul Man; Jiri Frohlich; John E Connett; Nick R Anthonisen; Robert A Wise; Donald P Tashkin; Don D Sin Journal: Eur Heart J Date: 2011-06-08 Impact factor: 29.983
Authors: Harry Hemingway; Peter Philipson; Ruoling Chen; Natalie K Fitzpatrick; Jacqueline Damant; Martin Shipley; Keith R Abrams; Santiago Moreno; Kate S L McAllister; Stephen Palmer; Juan Carlos Kaski; Adam D Timmis; Aroon D Hingorani Journal: PLoS Med Date: 2010-06-01 Impact factor: 11.069
Authors: Muredach P Reilly; Mingyao Li; Jing He; Jane F Ferguson; Ioannis M Stylianou; Nehal N Mehta; Mary Susan Burnett; Joseph M Devaney; Christopher W Knouff; John R Thompson; Benjamin D Horne; Alexandre F R Stewart; Themistocles L Assimes; Philipp S Wild; Hooman Allayee; Patrick Linsel Nitschke; Riyaz S Patel; Nicola Martinelli; Domenico Girelli; Arshed A Quyyumi; Jeffrey L Anderson; Jeanette Erdmann; Alistair S Hall; Heribert Schunkert; Thomas Quertermous; Stefan Blankenberg; Stanley L Hazen; Robert Roberts; Sekar Kathiresan; Nilesh J Samani; Stephen E Epstein; Daniel J Rader Journal: Lancet Date: 2011-01-14 Impact factor: 79.321
Authors: Teresa Infante; Ernesto Forte; Concetta Schiano; Carlo Cavaliere; Carlo Tedeschi; Andrea Soricelli; Marco Salvatore; Claudio Napoli Journal: Am J Transl Res Date: 2017-07-15 Impact factor: 4.060
Authors: Jessica M Scott; Saro Armenian; Sergio Giralt; Javid Moslehi; Thomas Wang; Lee W Jones Journal: Crit Rev Oncol Hematol Date: 2015-11-17 Impact factor: 6.312
Authors: Muhammad Hammadah; Samaah Sullivan; Brad Pearce; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Ayman Samman Tahhan; Wesley T O'Neal; Malik Obideen; Ayman Alkhoder; Naser Abdelhadi; Heval Mohamed Kelli; Mohamad Mazen Ghafeer; Pratik Pimple; Pratik Sandesara; Amit J Shah; Kareem Mohammed Hosny; Laura Ward; Yi-An Ko; Yan V Sun; Lei Weng; Michael Kutner; J Douglas Bremner; David S Sheps; Fabio Esteves; Paolo Raggi; Viola Vaccarino; Arshed A Quyyumi Journal: Brain Behav Immun Date: 2017-10-03 Impact factor: 7.217
Authors: Nima Ghasemzedah; Salim S Hayek; Yi-An Ko; Danny J Eapen; Riyaz S Patel; Pankaj Manocha; Hatem Al Kassem; Mohamed Khayata; Emir Veledar; Dimitrios Kremastinos; Christian W Thorball; Tomasz Pielak; Sergey Sikora; A Maziar Zafari; Stamatios Lerakis; Laurence Sperling; Viola Vaccarino; Stephen E Epstein; Arshed A Quyyumi Journal: Circ Cardiovasc Qual Outcomes Date: 2017-03